| A tiling resolution DNA microarray with complete coverage of the human genome AS Ishkanian, CA Malloff, SK Watson, RJ DeLeeuw, B Chi, BP Coe, ... Nature genetics 36 (3), 299-303, 2004 | 804 | 2004 |
| Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ... The lancet oncology 15 (13), 1521-1532, 2014 | 376 | 2014 |
| Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer M Milosevic, P Warde, C Ménard, P Chung, A Toi, A Ishkanian, M McLean, ... Clinical cancer research 18 (7), 2108-2114, 2012 | 297 | 2012 |
| Copy number alterations of c‐MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy G Zafarana, AS Ishkanian, CA Malloff, JA Locke, J Sykes, J Thoms, ... Cancer 118 (16), 4053-4062, 2012 | 152 | 2012 |
| Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies R Stoyanova, A Pollack, M Takhar, C Lynne, N Parra, LLC Lam, ... Oncotarget 7 (33), 53362, 2016 | 114 | 2016 |
| High‐resolution array CGH identifies novel regions of genomic alteration in intermediate‐risk prostate cancer AS Ishkanian, CA Mallof, J Ho, A Meng, M Albert, A Syed, ... The Prostate 69 (10), 1091-1100, 2009 | 102 | 2009 |
| Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer C Garnis, BP Coe, A Ishkanian, L Zhang, MP Rosin, WL Lam Genes, Chromosomes and Cancer 39 (1), 93-98, 2004 | 85 | 2004 |
| NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy JA Locke, G Zafarana, AS Ishkanian, M Milosevic, J Thoms, CL Have, ... Clinical cancer research 18 (1), 308-316, 2012 | 59 | 2012 |
| Upfront observation versus radiation for adult pilocytic astrocytoma A Ishkanian, NJ Laperriere, W Xu, BA Millar, D Payne, W Mason, ... Cancer 117 (17), 4070-4079, 2011 | 57 | 2011 |
| Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma CM McKee, D Xu, Y Cao, S Kabraji, D Allen, V Kersemans, J Beech, ... The Journal of clinical investigation 122 (11), 4025-4036, 2012 | 56 | 2012 |
| An efficient method for the assessment of DNA quality of archival microdissected specimens A Siwoski, A Ishkanian, C Garnis, L Zhang, M Rosin, WL Lam Modern pathology 15 (8), 889-892, 2002 | 56 | 2002 |
| Developing a predictive model for clinical outcomes of advanced non-small cell lung cancer patients treated with nivolumab W Park, D Kwon, D Saravia, A Desai, F Vargas, M El Dinali, J Warsch, ... Clinical lung cancer 19 (3), 280-288. e4, 2018 | 54 | 2018 |
| TMPRSS2-ERG Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair A Dal Pra, E Lalonde, J Sykes, F Warde, A Ishkanian, A Meng, C Maloff, ... Clinical cancer research 19 (18), 5202-5209, 2013 | 50 | 2013 |
| Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer AS Ishkanian, G Zafarana, J Thoms, RG Bristow Acta oncologica 49 (7), 888-894, 2010 | 43 | 2010 |
| NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancer A Berlin, E Lalonde, J Sykes, G Zafarana, KC Chu, VR Ramnarine, ... Oncotarget 5 (22), 11081, 2014 | 40 | 2014 |
| Radiation-induced enhancement of antitumor T-cell immunity by VEGF-targeted 4-1BB costimulation B Schrand, B Verma, A Levay, S Patel, I Castro, AP Benaduce, ... Cancer research 77 (6), 1310-1321, 2017 | 37 | 2017 |
| Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays SK Watson, RJ DeLeeuw, AS Ishkanian, CA Malloff, WL Lam BMC genomics 5, 1-8, 2004 | 33 | 2004 |
| 4-1BB aptamer-based immunomodulation enhances the therapeutic index of radiation therapy in murine tumor models AP Benaduce, R Brenneman, B Schrand, A Pollack, E Gilboa, A Ishkanian International Journal of Radiation Oncology* Biology* Physics 96 (2), 458-461, 2016 | 15 | 2016 |
| Posterior sternoclavicular joint dislocation: case report and discussion N Kuzak, A Ishkanian, RB Abu-Laban Canadian Journal of Emergency Medicine 8 (5), 355-357, 2006 | 13 | 2006 |
| P1. 07-025 correlating ISEND and tumor mutation burden (TMB) with clinical outcomes of advanced non-small cell lung cancer (ANSCLC) patients on nivolumab W Park, G Lopes, D Kwon, V Florou, YK Chae, J Warsch, A Ishkanian, ... Journal of Thoracic Oncology 12 (11), S2005-S2006, 2017 | 8 | 2017 |
